欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）
MR编号
FI/H/1191/002
药品名称
Moxifloxacin Orion
活性成分
moxifloxacin 1.6 mg
剂型
Solution for infusion
上市许可持有人
Orion Corporation Orionintie 1 FI-02200 Espoo Finland
参考成员国 - 产品名称
Finland (FI)
互认成员国 - 产品名称
Denmark (DK)
Sweden (SE)
许可日期
2015/09/18
最近更新日期
2024/06/18
药物ATC编码
J01MA14 moxifloxacin
申请类型
TypeLevel1：
[not specified]
TypeLevel2：
[not specified]
TypeLevel3：
[not specified]
TypeLevel4：
[not specified]
TypeLevel5：
[not specified]
附件文件下载
Final SPC
|
Moxifloxacin_Orion_Tablet_SPC_Clean
Date of last change:2021/04/08
Final SPC
|
Moxifloxacin_Orion_Infusion_SPC_Clean
Date of last change:2021/04/08
Final PL
|
Moxifloxacin_Orion_Infusion_PIL_Clean
Date of last change:2021/04/08
Final PL
|
Moxifloxacin_Orion_Tablet_PIL_Clean
Date of last change:2021/04/08
Final Labelling
|
Common_LAB_Moxifloxacin_Orion_Inf_Clean
Date of last change:2018/06/19
Final Labelling
|
Common_LAB_Moxifloxacin_Orion_Tab_Clean
Date of last change:2018/06/19
Final Product Information
|
Moxifloxacin Orion 400mg_250ml inf DCP SPC 260617clean
Date of last change:2017/10/30
Final Product Information
|
Moxifloxacin Orion 400mg tabl DCP PIL 260617clean
Date of last change:2017/10/30
Final Product Information
|
Moxifloxacin Orion 400mg tablet DCP SPC 260617clean
Date of last change:2017/10/30
Final Product Information
|
Moxifloxacin Orion 400mg_250ml inf DCP PIL 260617clean
Date of last change:2017/10/30
PAR
|
PAR Moxifloxacin Orion inf
Date of last change:2015/12/17
PAR Summary
|
PAR summary Moxifloxacin Orion inf
Date of last change:2015/12/17
市场状态
Positive
©2006-2024
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase